Description

Ths edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) 26 innovation stories across microbiome, small molecules, infectious disease diagnostics, biologics, and several other biotech platforms. The TOE also provides technological, application and megatrends impact, apart from exclusive analyst insights across each technology platform.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Viome, artificial intelligence, mega trends, disruption, microbiome, Watercress, superfood, dysbiosis, Ixcela, probiotics, precision medicine, DayTwo, glycemia, Targedys, Nanopore, Sequencing, Daktari, diagnostic, inui, smartphone, viral vector, gene delivery, B-MoGen, Forty Seven, check-point inhibitor, Genocea, immunology, cancer, Gritstone, Autolus, Arcus, MODAG, multiple system atrophy, Encoded, gene therapy, Adaptive, Dundee, Protac, SAGA, liquid biopsy, MedRhythms, BlackThorn, Genome Medical, Fractyl Labs, Refuge, cell therapies, Excision BioTherapeutics, gene editing, Poxel, Imeglimin